Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
- 15 August 1992
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 89 (16), 7422-7426
- https://doi.org/10.1073/pnas.89.16.7422
Abstract
Tissue-type plasminogen activator and urokinase are serine proteases secreted by many cell types that participate in biological processes, such as tissue restructuring, cell migration, and tumor metastasis. Clinically, these proteases are used to dissolve coronary fibrin clots that are the proximal causes of acute myocardial infarction. In vivo, the activity of these enzymes is controlled by plasminogen-activator inhibitors, members of the serpin family of protease inhibitors. This study shows that tissue-type plasminogen activator-inhibitor complexes bind in solution to low density lipoprotein receptor-related protein (LRP), a large heterodimeric ubiquitous membrane receptor. In cultured cells, endocytosis and degradation of these complexes is reduced by polyclonal antibodies directed against LRP and inhibited by a M(r) 39,000 protein that binds to LRP and inhibits its interaction with previously known ligands, including apolipoprotein E and alpha 2-macroglobulin. We propose a role for LRP in the clearance of plasminogen activator-inhibitor complexes that is analogous to its function in the endocytosis of alpha 2-macroglobulin-protease complexes.Keywords
This publication has 28 references indexed in Scilit:
- Tyrosine 67 in the epidermal growth factor-like domain of tissue-type plasminogen activator is important for clearance by a specific hepatic receptor.Journal of Biological Chemistry, 1992
- 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.Journal of Biological Chemistry, 1991
- High resolution analysis of functional determinants on human tissue-type plasminogen activator.Journal of Biological Chemistry, 1991
- Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cellsThrombosis Research, 1990
- Evidence that the newly cloned low‐density‐lipoprotein receptor related protein (LRP) is the α2‐macroglobulin receptorFEBS Letters, 1990
- The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.The Journal of cell biology, 1990
- Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.Journal of Biological Chemistry, 1990
- Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.The Journal of cell biology, 1989
- Plasminogen Activators, Tissue Degradation, and CancerAdvances in Cancer Research, 1985
- Turnover of Human Extrinsic (Tissue-Type) Plasminogen Activator in RabbitsThrombosis and Haemostasis, 1981